Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Zogenix Inc. : Trading of Zogenix Common Stock Halted

12/07/2012 | 08:00am US/Eastern

FDA Advisory Committee Reviewing Zohydro™ ER New Drug Application

Zogenix to Host Conference Call at 6:30 pm ET Today

SAN DIEGO, Dec. 7, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, announced that NASDAQ halted trading of the company's common stock on December 7, 2012. The U.S. Food and Drug Administration's (FDA) Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) is meeting today to review the Company's New Drug Application (NDA) for Zohydro™ ER (hydrocodone bitartrate extended-release capsules).

Conference Call & Webcast

Zogenix will host a conference call to discuss the outcome of the AADPAC meeting today, Friday, December 7, 2012 at 6:30 p.m. ET (3:30 p.m. PT). To participate, please dial (800) 299-9086 (U.S.) or (617) 786-2903 (International); participant passcode: 21970283. To access the live webcast please visit the Zogenix Investor Relations website at http://ir.zogenix.com.  

The conference call will be hosted by Chief Executive Officer Roger L. Hawley and President and Chief Operating Officer Stephen J. Farr, Ph.D.

A replay of the conference call will be available beginning December 7, 2012 at 8:30 p.m. ET (5:30 p.m. PT) until December 14, 2012, by dialing (888) 286-8010 (U.S.) or (617) 801-6888 (International); passcode: 27116437. A replay of the webcast will also be accessible on the Investor Relations website for one month, through January 10, 2013.

About Anesthetic and Analgesic Drug Products Advisory Committee

The AADPAC reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human anesthetic and analgesic drug products and makes appropriate recommendations to the Commissioner of Food and Drugs. The AADPAC provides FDA with independent expert advice and recommendations, however, the final decision regarding approval is made by FDA.

About Zogenix

Zogenix, Inc., with offices in San Diego and Emeryville, California, is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. Zogenix's first commercial product, SUMAVEL® DosePro® (sumatriptan injection) Needle-free Delivery System, was launched in January 2010 for the acute treatment of migraine and cluster headache. Zogenix's lead investigational product candidate, ZohydroTM ER (hydrocodone bitartrate) is an oral, novel extended-release formulation of various strengths of hydrocodone without acetaminophen intended for administration every 12 hours for around the clock management of moderate to severe chronic pain. Zogenix's second DosePro investigational product candidate, ReldayTM, is a proprietary, long-acting injectable formulation of risperidone for the treatment of schizophrenia. In May 2012, Zogenix submitted to the FDA a New Drug Application for Zohydro ER and an Investigational New Drug Application for Relday. The FDA assigned a PDUFA target action date of March 1, 2013 for the Zohydro ER NDA.

For additional information, please visit www.zogenix.com.

SUMAVEL ®, DosePro ®, ReldayTM and ZohydroTM ER are trademarks of Zogenix, Inc.

CONTACT: INVESTORS:
         Zack Kubow | The Ruth Group
         646.536.7020 | zkubow@theruthgroup.com

         MEDIA:
         Emily Poe | WCG
         212.301.7183 | epoe@wcgworld.com
Zogenix
distributed by
React to this article
Latest news
Date Title
03:15a PORSCHE AUTOMOBIL SE : DC authorities: Ex-con had help in wealthy family's slaying
03:05a HYUNDAI HCN : Double Military Rebate, Now $1000.00 Off on Any New Hyundai at Findlay Hyundai in Post Falls, Idaho
03:04a ARISTA NETWORKS : Intelligent Visibility Releases the Arista Navigator
03:04a HARLEY DAVIDSON : BRIEF: Motorcyclist killed after hitting deer near Rochester
03:01a SAP SE : zedSuite Introduces zed Customer Portal Version for SAP Business One Powered by the SAP HANA® Platform
03:01a CITY OF NEW ORLEANS LA : Mayor Landrieu Issues Statement on Passage of Trade Promotion Authority by Senate
02:44a RYANAIR : SATURDAY, MAY 23, 2015 @LIVECHONEWS ECHO EIRE-PORT BOOST ; Ryanair increases flights to Dublin after Aer Lingus announcement
02:44a JUVENTUS FOOTBALL CLUB : Quarter-final
02:38a ROYAL DUTCH SHELL A : Woman chains herself to Shell ship in bay north of Seattle
02:26a EIFFAGE : CONSTELLATIONSLiverpool Playhouse ; Review
Latest news
Advertisement
Hot News 
AMUR MINERALS : Kun-Manie Production Licence Awarded
CTRIP : Expedia Announces eLong Transaction
HAVELOCK EUROPA : Looks to the Future of Manufacturing in Fife
MIKRON : visiting a great British dish and a national institution ; DRAMA
SOITEC : Frances Soitec to sell solar activities to ConcenSolar
Most Read News
05/22 ETSY : BRIEF: Amazon reportedly set to debut Etsy rival dubbed Handmade
05/22 BLACKBERRY : cuts jobs worldwide as it consolidates businesses
05/22 SAJAN : Wrenching case of man dying in Austin hospital spurs feud over care
05/22 SIMON PROPERTY : Officials: Whistle-blower in Simon Property Group theft case found dead
05/22 TELEFONICA : Landing of submarine fiber-optic cable in Puerto Rico delayed
Most recommended articles
05/22 Yellen tone suggests choppiness for markets ahead
05/22DJSenate Passes Fast-Track Trade Legislation -- Update
05/22 A Fundamental Push for Key EURUSD, GBPUSD and USDJPY Levels?
05/22 US Dollar Recovery Fighting Liquidity, Growth Headwinds
05/22 BLACKBERRY : cuts jobs worldwide as it consolidates businesses